SG11202102818YA - Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness - Google Patents
Ophthalmic compositions for treatment of ocular surface damage and symptoms of drynessInfo
- Publication number
- SG11202102818YA SG11202102818YA SG11202102818YA SG11202102818YA SG11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- patient
- dryness
- ocular surface
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18196126 | 2018-09-22 | ||
| EP18198440 | 2018-10-03 | ||
| EP18202041 | 2018-10-23 | ||
| PCT/EP2019/075406 WO2020058504A1 (en) | 2018-09-22 | 2019-09-20 | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202102818YA true SG11202102818YA (en) | 2021-04-29 |
Family
ID=68240699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202102818YA SG11202102818YA (en) | 2018-09-22 | 2019-09-20 | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210346313A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3852734A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022500461A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210080388A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112739335A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019342426A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3111873A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL281516A (cg-RX-API-DMAC7.html) |
| PH (1) | PH12021550621A1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202102818YA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020058504A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170087100A1 (en) | 2015-09-30 | 2017-03-30 | Novaliq Gmbh | Semifluorinated compounds and their compositions |
| DK3442480T3 (da) | 2016-06-23 | 2020-01-13 | Novaliq Gmbh | Fremgangsmåde til topisk indgivelse |
| KR102614858B1 (ko) | 2016-09-22 | 2023-12-18 | 노바리크 게엠베하 | 안검염 치료에 사용되는 약제학적 조성물 |
| AU2017329983B2 (en) | 2016-09-23 | 2022-05-05 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
| MX381639B (es) | 2016-12-23 | 2025-03-13 | Novaliq Gmbh | Composicion oftalmica para el tratamiento de la enfermedad del ojo seco. |
| PL3612228T3 (pl) | 2017-04-21 | 2024-04-08 | Dermaliq Therapeutics, Inc. | Kompozycje jodu |
| JP7814839B2 (ja) | 2017-09-27 | 2026-02-17 | ノバリック ゲーエムベーハー | 眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物 |
| CN111182893A (zh) | 2017-10-04 | 2020-05-19 | 诺瓦利克有限责任公司 | 包含f6h8的眼用组合物 |
| US11576893B2 (en) | 2018-03-02 | 2023-02-14 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
| AU2019246035B2 (en) | 2018-03-28 | 2024-07-18 | Novaliq Gmbh | Pharmaceutical composition comprising timolol |
| JP7855312B2 (ja) | 2018-04-27 | 2026-05-08 | ノバリック ゲーエムベーハー | 緑内障の治療のためのタフルプロストを含む眼科用組成物 |
| EP3923907B1 (en) | 2019-02-13 | 2024-09-25 | Novaliq GmbH | Compositions and methods for the treatment of ocular neovascularization |
| CN114449999A (zh) | 2019-09-06 | 2022-05-06 | 诺瓦利克有限责任公司 | 用于治疗葡萄膜炎的眼用组合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19938668B4 (de) | 1999-08-14 | 2006-01-26 | Bausch & Lomb Inc. | Tränenersatzmittel |
| WO2003088906A2 (en) * | 2002-04-16 | 2003-10-30 | Collagenex Pharmaceuticals, Inc. | Methods of simultaneously treating ocular rosacea and acne rosacea |
| EP2187900B1 (en) * | 2007-08-16 | 2016-11-09 | The Schepens Eye Research Institute, Inc. | Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues |
| EP2335735A1 (en) | 2009-12-14 | 2011-06-22 | Novaliq GmbH | Pharmaceutical composition for treatment of dry eye syndrome |
| EP2895144B1 (en) * | 2012-09-12 | 2017-01-11 | Novaliq GmbH | Semifluorinated alkane compositions |
| MX363182B (es) * | 2012-09-12 | 2019-03-13 | Novaliq Gmbh | Composiciones que comprenden mezclas de alcanos semifluorados. |
| EP3187168B1 (en) * | 2014-10-09 | 2020-03-18 | Mediproduce Inc. | Eyelash cleaning agent |
| US20170087100A1 (en) * | 2015-09-30 | 2017-03-30 | Novaliq Gmbh | Semifluorinated compounds and their compositions |
| KR102614858B1 (ko) * | 2016-09-22 | 2023-12-18 | 노바리크 게엠베하 | 안검염 치료에 사용되는 약제학적 조성물 |
| CN111182893A (zh) * | 2017-10-04 | 2020-05-19 | 诺瓦利克有限责任公司 | 包含f6h8的眼用组合物 |
-
2019
- 2019-09-20 EP EP19786907.6A patent/EP3852734A1/en active Pending
- 2019-09-20 CA CA3111873A patent/CA3111873A1/en active Pending
- 2019-09-20 AU AU2019342426A patent/AU2019342426A1/en not_active Abandoned
- 2019-09-20 WO PCT/EP2019/075406 patent/WO2020058504A1/en not_active Ceased
- 2019-09-20 US US17/278,585 patent/US20210346313A1/en not_active Abandoned
- 2019-09-20 CN CN201980062052.2A patent/CN112739335A/zh active Pending
- 2019-09-20 KR KR1020217011860A patent/KR20210080388A/ko active Pending
- 2019-09-20 SG SG11202102818YA patent/SG11202102818YA/en unknown
- 2019-09-20 JP JP2021514550A patent/JP2022500461A/ja active Pending
-
2021
- 2021-03-15 IL IL281516A patent/IL281516A/en unknown
- 2021-03-18 PH PH12021550621A patent/PH12021550621A1/en unknown
-
2025
- 2025-06-06 US US19/231,354 patent/US20250295607A1/en not_active Abandoned
- 2025-06-10 AU AU2025204313A patent/AU2025204313A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210080388A (ko) | 2021-06-30 |
| EP3852734A1 (en) | 2021-07-28 |
| US20250295607A1 (en) | 2025-09-25 |
| PH12021550621A1 (en) | 2022-02-14 |
| JP2022500461A (ja) | 2022-01-04 |
| US20210346313A1 (en) | 2021-11-11 |
| WO2020058504A1 (en) | 2020-03-26 |
| AU2025204313A1 (en) | 2025-06-26 |
| IL281516A (en) | 2021-04-29 |
| AU2019342426A1 (en) | 2021-05-20 |
| CA3111873A1 (en) | 2020-03-26 |
| CN112739335A (zh) | 2021-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278178A (en) | Use of pilocarpine hydrochloride to treat eye disorder | |
| IL281773B2 (en) | Ophthalmic preparation for the treatment of dry eye disease | |
| PH12021550621A1 (en) | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness | |
| IL273531A (en) | Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases | |
| IL284344A (en) | Pharmaceutical preparations for the eyes and methods for the treatment of diseases of the surface of the eye | |
| PT3399962T (pt) | Composição oftálmica para o tratamento da doença do olho seco | |
| EP3463315C0 (en) | COMPOSITIONS AND METHODS OF USE OF NINTEDANIB FOR THE TREATMENT OF ABNORMAL NEOVASCULARIZATION OCULAR DISEASES | |
| SG11202102615RA (en) | Methods and compositions for ocular cell therapy | |
| ZA202002991B (en) | Methods and compositions for assessing and treating intraocular diseases and disorders | |
| IL287802A (en) | Preparations and methods for the treatment of eye diseases | |
| IL277557A (en) | Self-assembling peptidomimetics and peptidomimetics for the treatment of eye diseases | |
| ZA202107235B (en) | Compositions and methods for treating ocular disease | |
| SMT202300093T1 (it) | Composizione oftalmica nutraceutica per il trattamento di patologie retiniche a componente neovascolare | |
| EP3691654A4 (en) | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES | |
| PL3493823T4 (pl) | Składnik na bazie postbiotyki do leczenia zapalenia oka | |
| SMT201900621T1 (it) | Composizione oftalmica per l'uso nel trattamento dei disturbi dell'occhio relativi alle alterazioni della superficie corneale-congiuntivale | |
| PT4031117T (pt) | Mutante do ngf para utilização no tratamento ou prevenção de distúrbios oftálmicos | |
| EP3644966A4 (en) | TREATMENT AND DIAGNOSIS OF EYE SURFACE DISORDERS | |
| SG11202012473UA (en) | Ophthalmic compositions and methods for the treatment of eye disorders | |
| IL287441A (en) | Preparations and methods of use for the treatment of dry eye | |
| SG11202004940VA (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
| HK40058269A (en) | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness | |
| IL282898A (en) | Ophthalmic compounds and methods for treating skin and eye diseases | |
| IL280588A (en) | Ophthalmic compositions and methods for treating eye problems and skin diseases | |
| HK40033459A (en) | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |